Skip to main content
Pier Scaglioni, MD, Oncology, Cincinnati, OH

PierPScaglioniMD

Oncology Cincinnati, OH

Hematologic Oncology

Professor Department of Internal Medicine Division of Hematology/Oncology Medical Director UC Health Barrett Cancer Center University of Cincinnati Medical College 3125 Eden Avenue, Rm. 3118 Cincinnati, OH 45219-2293

Dr. Scaglioni is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Scaglioni's full profile

Already have an account?

  • Office

    3130 Highland Ave
    Cincinnati, OH 45219
    Phone+1 513-475-8500
    Fax+1 513-584-4281

Summary

  • Dr. Pier Scaglioni is an oncologist in Cincinnati, OH and is affiliated with University of Cincinnati Medical Center. He received his medical degree from University of Modena Faculty of Medicine and has been in practice 28 years. He also speaks multiple languages, including Italian and Spanish. He specializes in hematologic oncology and is experienced in acute leukemias and malignant hematology.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2001 - 2004
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1998 - 2001
  • University of Modena Faculty of Medicine
    University of Modena Faculty of MedicineClass of 1989

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2017 - 2026
  • TX State Medical License
    TX State Medical License 2007 - 2018
  • NY State Medical License
    NY State Medical License 2001 - 2007
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • CDK4/6 Inhibitors Explored in KRAS-Mutant Cancers
    CDK4/6 Inhibitors Explored in KRAS-Mutant CancersOctober 31st, 2017

Grant Support

  • Defining and Defeating Mechanistic Subtypes of KRAS-mutant Lung CancersCPRIT2016–Present
  • Mutant KRAS reprograms lipid metabolism exposing beta-oxidation as a novel therapeutic target in lung cancer lung cancerCPRIT2014–Present
  • Identification of critical components of the K-RAS network in lung cancerAmerican Cancer Society Scholar Award2012–2017
  • Deconstruction of oncogenic K-RAS signaling reveals focal adhesion kinase as a novel therapeutic target in NSCLCDepartment of defense2012–2016
  • Characterization And Drug Targeting Of The PML Tumor Suppressor In Lung CancerNational Cancer Institute2009–2011
  • Post-Transcriptional Regulation Of PML FunctionNational Cancer Institute2006–2009
  • Post-Transcriptional Regulation Of PML FunctionNational Cancer Institute2005–2006

Other Languages

  • Italian, Spanish